BIOMAT Database Logo BIOMAT Database Logo

Coagulation disorders in cancer. 3. Fibrinolysis and inhibitors. 1970

B C Soong, and S P Miller

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B C Soong, and S P Miller
[Management of coagulation and fibrinolysis disorders in patients with cancer].
January 2000, Pneumonologia i alergologia polska,
B C Soong, and S P Miller
[Inhibitors of coagulation and of fibrinolysis].
January 1985, Sangre,
B C Soong, and S P Miller
[Inhibitors of coagulation and fibrinolysis in diabetics].
June 1988, Vnitrni lekarstvi,
B C Soong, and S P Miller
Coagulation activation, fibrinolysis and inhibitors in neonates.
November 1997, Annals of the Academy of Medicine, Singapore,
B C Soong, and S P Miller
Normal blood coagulation, fibrinolysis, and natural inhibitors of coagulation.
January 1985, International anesthesiology clinics,
B C Soong, and S P Miller
Coagulation and fibrinolysis in cancer.
April 1992, Behring Institute Mitteilungen,
B C Soong, and S P Miller
[Coagulation/fibrinolysis disorders in the elderly].
March 2000, Rinsho byori. The Japanese journal of clinical pathology,
B C Soong, and S P Miller
Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.
July 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
B C Soong, and S P Miller
[Coagulation, fibrinolysis and various diseases: cerebrovascular disorders].
May 1974, Nihon rinsho. Japanese journal of clinical medicine,
B C Soong, and S P Miller
[Disorders of coagulation/fibrinolysis and bleeding tendency].
January 1994, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!